The price of Curevac (CVAC), a german pharma pursuing NEW GENERATION m-RNA VACCINEs, has been performing a correction (Pull Back) in the last days. The future of the company is excellent with many products in pipeline and taking part of Melinda-Gates foundation programs.
What I observed, aside the pull-back, and want to share here is three small gaps that have to...
Curevac (CVAC) is increasing price action and gaining momentum over the past few days. New mRNA vaccine and agreements of UE to provide China with vaccines will be triggering very soon a Rally. Lots of volume and gaps are giving rise to isolated price "island". In the graph is is visible three goal that price will be reaching to close gaps. Stay tunned and load as...
El pasado jueves, las acciones de la compañía biofarmacéutica alemana CureVac se desplomaron después de que se demostró que la eficacia de su vacuna contra el Covid-19 es de tan sólo del 47%. Hasta ahora esta es una de las cifras más bajas reportadas por cualquier fabricante de vacunas del Covid-19.
El fármaco utiliza la misma tecnología que las de...
